- Advisors to the Food and Drug Administration (FDA) will start to develop a long-term strategy for COVID-19 vaccinations. The discussion is expected to include the viability of an annual COVID-19 vaccine, which would require scientific models to predict how COVID-19 will mutate, and eligibility for additional boosters and the optimal timing to administer them. If the panel decides to recommend annual vaccines, regulators would have to choose which strains a vaccine should target and manufacturers would need considerable lead time to make potentially hundreds of millions of doses of modified vaccine. (Articles here, here, here, and here)
April 6, 2022
Life Sciences